Generic version of a drug already on the market, which can suppress and prevent HIV, would still yield 30% profit if the current price was slashed, researchers say
Kat Lay, Global health correspondent, in Munich
Tue 23 Jul 2024 04.00 EDT
A new drug described as “the closest we have…
[ad_2]
Source link
